I 
116TH CONGRESS 
2D SESSION 
H. R. 8121 
To require the Consumer Product Safety Commission to study the effect 
of the COVID–19 pandemic on injuries and deaths associated with con-
sumer products, and for other purposes. 
IN THE HOUSE OF REPRESENTATIVES 
AUGUST 28, 2020 
Mr. CA´RDENAS (for himself and Mr. RODNEY DAVIS of Illinois) introduced the 
following bill; which was referred to the Committee on Energy and Commerce 
A BILL 
To require the Consumer Product Safety Commission to 
study the effect of the COVID–19 pandemic on injuries 
and deaths associated with consumer products, and for 
other purposes. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘COVID–19 Home 
Safety Act of 2020’’. 
SEC. 2. REPORT. 
(a) COVID-19 REPORT REQUIRED.—Not later than 
3 months after the date of the enactment of this section 
VerDate Sep 11 2014 
22:19 Sep 04, 2020
Jkt 099200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H8121.IH
H8121
pbinns on DSKJLVW7X2PROD with BILLS
and every 3 months thereafter for the duration of the 
COVID–19 public health emergency, the Consumer Prod-
uct Safety Commission shall submit to the Committee on 
Energy and Commerce of the House of Representatives 
and the Committee on Commerce, Science, and Transpor-
tation of the Senate, and make publicly available, a report 
on the effect of the COVID–19 public health emergency 
on injuries and deaths from consumer products. 
(b) CONTENTS OF REPORT.—The report shall include 
the following: 
(1) Relevant data and statistics from— 
(A) the data sources of the Commission; 
(B) other appropriate agencies; 
(C) media reports; 
(D) poison control centers, to the extent 
practical; and 
(E) any other relevant data sources. 
(2) An identification of trends in injuries and 
deaths from consumer products, comparing data 
from representative time periods before and during 
the COVID–19 public health emergency. 
(3) An identification of subpopulations that 
have experienced elevated risk of injury or death 
from consumer products during the COVID–19 pub-
VerDate Sep 11 2014 
22:19 Sep 04, 2020
Jkt 099200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H8121.IH
H8121
pbinns on DSKJLVW7X2PROD with BILLS
lic health emergency, such as minorities, infants, 
people with disabilities, children, or the elderly. 
(4) An identification of where most injuries or 
deaths from consumer products during the COVID– 
19 public health emergency are taking place, such as 
the type of building or outdoor environment. 
(5) A specification about whether consumer 
products associated with a substantial number of in-
juries or deaths during the COVID–19 public health 
emergency are— 
(A) under recall; 
(B) subject to a voluntary consumer prod-
uct safety standard; or 
(C) subject to a mandatory consumer prod-
uct safety standard. 
(6) An identification of emerging consumer 
products that are posing new risks to consumers. 
(c) COVID–19 PUBLIC HEALTH EMERGENCY DE-
FINED.—The term ‘‘COVID–19 public health emergency’’ 
means a public health emergency declared pursuant to sec-
tion 319 of the Public Health Service Act (42 U.S.C. 
247d) as a result of confirmed cases of 2019 novel 
coronavirus (COVID–19), including any renewal thereof. 
Æ 
VerDate Sep 11 2014 
22:19 Sep 04, 2020
Jkt 099200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6301
E:\BILLS\H8121.IH
H8121
pbinns on DSKJLVW7X2PROD with BILLS